Nicotinamide as potential biomarker for Alzheimer’s disease: A translational study based on metabolomics

Overview of attention for article published in Frontiers in Molecular Biosciences, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 12 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 news story.

Nicotinamide as potential biomarker for Alzheimer's disease: A translational study based on metabolomics.

Alzforum, 27 Jan 2023

Dalmasso MC, Arán M, Galeano P, Perin S, Giavalisco P, Martino Adami PV, Novack GV, Castaño EM, Cuello AC, Scherer M, Maier W…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.